ArticleThe Journal of clinical investigation2021

Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer.

Deanna N Edwards et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.